16 February 2025 - Oral Presentation Free Paper

16 Feb 2025 10:30 12:00
Sipadan 1
Time Session
10:30
10:42
The CREAFORMO-004 study: A phase II study of HR070803 plus 5-fluoruracil/leucovorin and bevacizumab as second-line treatment in patients with metastatic colorectal cancer
AB-0099
Jianling Zou Presenter
10:54
11:06
Triplet chemoradiotherapy with paclitaxel for squamous-cell anal cancer: a phase III trial
AB-0016
Sergey Gordeyev Presenter
11:06
11:18
Purse string Ileostomy Closure with NegatIve Pressure Wound Therapy: a Prospective Cohort Study in Patients Undergoing Stoma Closure Compared to a Retrospective Cohort Study
AB-00130
Carolyn Chew Presenter
11:18
11:30
Unpacking Empty Pelvis Syndrome: Risk Factors and Reconstruction Outcomes After Pelvic Exenteration
AB-0073
James Lockhart Presenter
11:30
11:42
Value of pre-operative endoscopy and magnetic resonance imaging in predicting pathological complete response in patients with rectal cancer following neoadjuvant therapy
AB-0087
Trevor Yeung Presenter